Two independent medical committees tasked with advising the U.S. Food & Drug Administration (FDA) have overwhelmingly endorsed stronger label warnings for Levaquin and other fluoroquinolone antibiotics. While the FDA is not required to abide by the recommendations of its advisory … Continue reading
A third Risperdal gynecomastia trial has concluded in a Pennsylvania litigation that currently houses hundreds of similar claims. According to court records, it took jurors just 3 1/2 hours of deliberations to award nearly $1.8 million to the plaintiff, an … Continue reading
A woman who lost her mother to heart failure has filed a new Onglyza lawsuit alleging that AstraZeneca’s Type 2 diabetes medication was responsible. According to a report from the Cook County Record, the Plaintiff is seeking both compensatory and … Continue reading
The Pennsylvania litigation housing more than 1,500 Risperdal lawsuits continues to try cases over the drug’s alleged association with gynecomastia, a condition marked by excessive male breast growth. Court documents indicate that two Risperdal gynecomastia trials are currently underway in … Continue reading
Two U.S. Food & Drug Administration (FDA) advisory panels will meet next week to review fluoroquinolone antibiotics, a class of medications that includes Levaquin, Avelox and Cipro. The meeting is intended to review the risks and benefits of using fluoroquinolones … Continue reading
A federal judicial panel has opted to centralize two major products liability dockets, creating new multidistrict litigations for federally-filed Zofran birth defect claims and power morcellator lawsuits. The establishment of these new proceedings will promote judicial efficiency by allowing each … Continue reading
Litigation involving the Type 2 diabetes medication Invokana is heating up in Canada, where a proposed class action lawsuit was filed against the drug’s maker last month. Meanwhile, it and other SGLT2 inhibitors are coming under more scrutiny in the … Continue reading
The company behind last month’s ConforMIS knee recall is now facing a possible class action lawsuit for allegedly violating certain provisions of the Securities Exchange Act. The complaint, which was filed on September 17th in the U.S. District Court, District … Continue reading
Transvaginal mesh lawsuits filed against Ethicon, Inc. continue to move forward in courts around the U.S., as the country’s first trial involving the Prosima pelvic mesh device got underway last week in Dallas, Texas. According to a report from Law … Continue reading